Company / Total Assets
CAPRICOR THERAPEUTICS, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$355.9M
FY2025
5-year range
$41.3M / $355.9M
FY2021-FY2025
Trend
+108.8%
vs FY2024
Sector context
#168 of 214
Health Care
What the data says
CAPRICOR THERAPEUTICS, INC.'s total assets of $356M is lower than 79% of companies in the Health Care sector (FY2025). Total Assets has increased for 7 consecutive years, from $9M in FY2018 to $356M in FY2025.
Based on SEC 10-K filings.
$356M in FY2025 with a 5-year CAGR of +59.4%.
Improved from $59M to $356M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +92.2%
- 5-Year CAGR
- +59.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 214This company $355.9M Sector average $7.5B
▼
-95.2% below sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s total assets has grown for 7 consecutive years.
- 5-year CAGR of +59.4%, indicating consistent growth.
- In FY2025, total assets increased 108.8% year-over-year.
- Ranks #168 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $355.9M | +108.8% |
| FY2024 | $170.5M | +190.3% |
| FY2023 | $58.7M | +17.2% |
| FY2022 | $50.1M | +21.2% |
| FY2021 | $41.3M | +19.4% |
| FY2020 | $34.6M | +211.5% |
| FY2019 | $11.1M | +20.2% |
| FY2018 | $9.2M | -43.2% |
| FY2017 | $16.3M | -13.2% |
| FY2016 | $18.7M | +16.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026